Report of Foreign Issuer (6-k)
June 21 2016 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report
of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
the Month of June 2016
Commission
File Number
001-33042
Rosetta Genomics Ltd.
(Translation of registrant’s name into English)
10 Plaut Street, Science Park
Rehovot 76706, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
¨
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Rosetta Genomics Ltd.
On June 21, 2016, Rosetta Genomics Ltd.
(the “Company”) issued a press release announcing receipt of conditional approval from the New York State Department
of Health (NYSDOH) for the Company’s multiple fluorescence in situ hybridization (FISH) tests for detection of amplifications
or rearrangements of DNA in a number of hematologic cancers, such as leukemias, lymphomas and myelomas in order to form a
diagnosis
and/or to evaluate
prognosis
or
remission
of disease. A copy
of the press release is filed as Exhibit 99.1 to this Form 6-K and incorporated by reference herein.
The information contained in this Report
(including the exhibit hereto) is hereby incorporated by reference into the Company’s Registration Statements on Form F-3,
File Nos. 333-163063, 333-171203, 333-172655, 333-177670, 333-185338, 333-207697 and 333-210366.
Exhibits
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release dated June 21, 2016.
|
|
|
|
|
|
|
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ROSETTA GENOMICS LTD.
|
|
|
Date: June 21, 2016
|
By:
|
/s/ Kenneth Berlin
|
|
|
|
|
|
Kenneth Berlin
Chief Executive Officer and President
|
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Apr 2023 to Apr 2024